The proliferation of HepG2 within the tumor mass detected by PCNA, was significantly reduced in MV-HLSC treated tumors with respect to control mice injected with vehicle alone, with MV-RNase or with MV-CD29 (Fig. 2D; Supporting Information Fig. 2A). The gene discussed is ITGB1; the disease is neoplasm.